Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration

Published on July 18, 2024

The University of Oxford and Apollo Therapeutics, a portfolio biopharmaceutical company, announce the signing of a drug discovery and development collaboration aimed at translating breakthroughs made by biomedical researchers at Oxford.
Continue reading on website
Other news

Major donation creates new ‘Future Leaders’ MBA scholarship

July 18, 2024
The gift represents the largest single donation to Saïd Business School for MBA scholarships and will support the most academically talented students from around the world to take up a place at Oxford regardless of background.

Oxford academics elected 2024 British Academy Fellows

July 18, 2024
Nine academics from the University of Oxford have been elected Fellows of the British Academy for their distinguished contributions to research.